Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Xellia Pharmaceuticals ApS

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 2,958,004 More Arrow 3,360,059 Less Arrow 2,465,340
Earnings before taxes -3,168,294 More Arrow -381,008 Less Arrow -605,104
Total assets 3,133,962 More Arrow 5,178,202 Less Arrow 5,134,834
Current assets 1,969,223 Less Arrow 1,602,580 More Arrow 1,801,358
Current liabilities 3,042,051 Less Arrow 1,639,291 Less Arrow 1,249,492
Equity capital -889,977 More Arrow 2,619,856 More Arrow 2,864,317
- share capital 299,252 More Arrow 300,793 Less Arrow 276,429
Employees (average) 350 Equal arrow 350 Equal arrow 350

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency -28.4% More Arrow 50.6% More Arrow 55.8%
Turnover per employee 8,451 More Arrow 9,600 Less Arrow 7,044
Profit as a percentage of turnover -107.1% More Arrow -11.3% Less Arrow -24.5%
Return on assets (ROA)
Current ratio 64.7% More Arrow 97.8% More Arrow 144.2%
Return on equity (ROE) 356.0% Less Arrow -14.5% Less Arrow -21.1%
Change turnover -384,840 More Arrow 677,424 Less Arrow -343,664
Change turnover % -12% More Arrow 25% Less Arrow -12%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.